Restore Vision

About:

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Top Investors: SMBC Venture Capital, ANRI, Kyoto University Innovation Capital, Spiral Capital, DBJ Capital

Description:

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa. Restore Vision develops eye disease therapeutic agents.

Total Funding Amount:

2.47B JPY

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2016-11-14

Contact Email:

contact(AT)restore-vis.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-12-15

IPO Status:

Private

Industries: